Stock A288330 BRIDGE BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Bridge Biotherapeutics, Inc.

Equities

A288330

KR7288330004

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
2,095 KRW -4.99% Intraday chart for Bridge Biotherapeutics, Inc. +10.26% -36.23%
Mar. 28 Bridge Biotherapeutics Launches Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade CI
Mar. 26 Bridge Biotherapeutics Announces Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology CI

Business Summary

Bridge Biotherapeutics, Inc. is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The products mainly consist of ulcerative colitis medicine BBT-401, autoxin inhibitor BBT-877, non-small cell lung cancer medicine BBT-176, and others. The Company is also involved in the manufacture of basic pharmaceuticals and biologicals.

Number of employees: 36

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
- - 100 100.0 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
3,024 100.0 % 100 100.0 % -96.69%

Managers

Managers TitleAgeSince
Jeong-Gyu Lee FOU
 Founder 56 15-09-16
Sujin Jung COO
 Chief Operating Officer - -
Sang-Wook Kang CTO
 Chief Tech/Sci/R&D Officer 53 -

Members of the board

Members of the board TitleAgeSince
Seung-Yeob Baek BRD
 Director/Board Member 64 -
Seung-Hoon Lee BRD
 Director/Board Member 62 -
Jeong-Gyu Lee FOU
 Founder 56 15-09-16
Ju-Yeol Yoo BRD
 Director/Board Member 55 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 24,352,648 19,204,573 ( 78.86 %) 0 78.86 %

Shareholders

NameEquities%Valuation
Jeong-Gyu Lee
8.219 %
3,015,224 8.219 % 4 M ₩
UTC Investment Co., Ltd.
5.370 %
1,969,956 5.370 % 3 M ₩
Hae-seon Choi
4.027 %
1,477,401 4.027 % 2 M ₩
SV Investment Co ltd(Venture Capital)
3.966 %
1,455,041 3.966 % 2 M ₩
Bridge Biotherapeutics, Inc. ESOA
1.034 %
379,337 1.034 % 507 621 ₩
DAEWOONG CO., LTD.
0.7700 %
282,498 0.7700 % 378 033 ₩
Jong-Jin Lim
0.1585 %
58,143 0.1585 % 77 806 ₩
Yong-Hee Lee
0.0653 %
23,955 0.0653 % 32 056 ₩
Byong Kim
0.0625 %
22,944 0.0625 % 30 703 ₩
Jung-Soon Lee
0.0419 %
15,373 0.0419 % 20 572 ₩

Company contact information

Bridge Biotherapeutics, Inc.

58 Pangyo-ro 255beon-gil Bundang-gu

13486, Seongnam-si

+

http://www.bridgebiorx.com
address Bridge Biotherapeutics, Inc.(A288330)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
BRIDGE BIOTHERAPEUTICS, INC. Stock Bridge Biotherapeutics, Inc.
-36.23% 39.37M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+20.11% 127B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+25.24% 117B
ARGENX SE Stock argenx SE
+25.56% 27.77B
BIONTECH SE Stock BioNTech SE
-20.64% 20.44B
GENMAB A/S Stock Genmab A/S
-14.36% 16.62B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.50% 15.92B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-46.67% 14.94B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+12.79% 14.74B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+56.11% 14.38B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. A288330 Stock
  4. Company Bridge Biotherapeutics, Inc.